Supported in part by Accelerate Diagnostics.
The purpose of this P.A.C.E. ®-accredited five-part webinar series is to provide thorough coverage of key issues encountered when performing antimicrobial susceptibility testing (AST) within the clinical laboratory, including the detection of common and novel resistance mechanisms and the utility of antibiograms and antimicrobial stewardship in infection prevention.
and part 3
of this AST webinar series are currently available on demand.
Level of Instruction:
This is a self-study series with five, one-hour webinars. The webinars are previously recorded presentations. Each webinar will include a 50-minute presentation and a 10-minute Q&A.
The webinars' content does not build on the previous webinars in the series. All of the content is independent so learners can purchase only those that meet their needs.
This webinar is sold to individuals and not to institutions; therefore the purchaser’s webinar login access should not be share with others.
- The series is composed of five topics and they can be purchased singularly or as a bundle. The cost is $30 (ASM & CLSI members)/$45 (non-members)/ $5 for ASM Clinical Laboratory Scientist (CLS, MT, MLT, MLS) members per topic or a bundle price of $138 (ASM & CLSI members)/$207 (non-members)/ $25 for ASM Clinical Laboratory Scientist (CLS, MT, MLT, MLS) members for all five topics. The purchase price includes unlimited access to the webinars through May 31, 2020 and continuing education credit for the purchaser.
to become an ASM member. If you are a CLSI member, contact CLSI Marketing Contact, Shannon Sullivan at firstname.lastname@example.org
for the coupon code to take advantage of the member price. The CLSI coupon code cannot be used on top of an ASM member price.
- An institutional subscription is available for this course for $259 per webinar. Purchase of institutional subscriptions will allow access and CE credit for up to 10 users. Please call Nicole Jackson at 202-942-9257 to purchase an institutional subscription. Each user receives unlimited access to the webinars through May 31, 2020 and continuing education credit.
Continuing Education (CE) Credit:
Each presentation is approved for 1.0 P.A.C.E.® credit. CE credits can only be claimed by the purchaser. ASM is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. All presentations are recognized by the California Department of Health and Florida Department of Health and qualify for California and Florida CE credit toward license renewal.
- Gram-Positive Resistance Mechanisms & Testing: Staphylococcus, presented by Sandra Richter, M.D., D(ABMM), Cleveland Clinic.
- Gram-Positive Resistance Mechanisms & Testing: Enterococcus/Streptococcus, April Bobenchik, Ph.D., D(ABMM), Lifespan Laboratories.
- Gram-Negative Resistance Mechanisms & Testing: Enterobacteriaceae, Patricia Simner, Ph.D., D(ABMM), Johns Hopkins.
- Gram-Negative Resistance Mechanisms & Testing: Non-Enterobacteriaceae, Romney Humphries, Ph.D., D(ABMM), UCLA Health System.
Please email ASM if you require closed captioning.
- Infection Prevention and Stewardship: Implications Beyond the Lab, Donna Wolk, Ph.D., D(ABMM), Geisinger Health System.
Missed Accelerate Diagnostics' cutting-edge presentations at ASM Microbe 2018? Here's your chance to view them for free
Antibiotic Susceptibility Testing Direct from Positive Blood Cultures: Challenges and Opportunities for Pediatric and Immunocompromised Patients with Bacteremia
Antibiotic Susceptibility Testing Direct from Positive Blood Cultures: Challenges and Opportunities in the Academic Medical Center Setting
Providing phenotypic antimicrobial susceptibility results to clinicians can significantly affect patient outcomes and is, arguably, one of the most important activities performed by clinical microbiology laboratories. This symposium focused on direct from positive blood culture phenotypic antibiotic susceptibility testing and the challenges and opportunities in integrating this new technology into antimicrobial stewardship programs. Additionally, presenters discussed the impact of early susceptibility results on the management patients with Gram-negative bacteremia.
If you are purchasing all five topics click this “Add to Cart” to get the bundle price. Adding all topics to your cart individually will result in a higher fee.